Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer
Christian Bailly
European Journal of Pharmacology (2022) Vol. 931, pp. 175191-175191
Closed Access | Times Cited: 23

Showing 23 citing articles:

Insights into tumor-derived exosome inhibition in cancer therapy
Ziwei Tang, Cheng Chen, Chen Zhou, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117278-117278
Closed Access | Times Cited: 1
Novel acetic acid derivatives containing quinazolin‐4(3H)‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors
Feyzi Sinan Tokalı, Yeliz Demir, Cüneyt Türkeş, et al.
Drug Development Research (2023) Vol. 84, Iss. 2, pp. 275-295
Closed Access | Times Cited: 36
Ferroptosis: The Entanglement between Traditional Drugs and Nanodrugs in Tumor Therapy
Kexuan Liu, Lei Huang, Shuangyan Qi, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 12
Closed Access | Times Cited: 36
Novel bis-pocket binding aldose reductase inhibitors sensitize MCF-7/ADR cells to doxorubicin in a dual-role manner
Chao Zhang, Shuling Peng, Ziyou Zheng, et al.
Bioorganic Chemistry (2025), pp. 108286-108286
Closed Access
Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp
Mohamad Ali Hijazi, André Gessner, Nahed El‐Najjar
Cancers (2023) Vol. 15, Iss. 12, pp. 3199-3199
Open Access | Times Cited: 16
In Search for Inhibitors of Human Aldo-Keto Reductase 1B10 (AKR1B10) as Novel Agents to Fight Cancer and Chemoresistance: Current State-of-the-Art and Prospects
Rosanna Maccari, Rosaria Ottanà
Journal of Medicinal Chemistry (2025)
Closed Access
Epalrestat Alleviates Reactive Oxygen Species and Endoplasmic Reticulum Stress by Maintaining Glycosylation in IMS32 Schwann Cells Under Exposure to Galactosemic Conditions
Hideji Yako, Naoko Niimi, Shizuka Takaku, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1529-1529
Open Access
Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids
Kanve N. Suvilesh, Yariswamy Manjunath, Yulia I. Nussbaum, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3855-3867
Closed Access | Times Cited: 4
Aldose reductase with quinolone antibiotics interaction: In vitro and in silico approach of its relationship with diabetic complications
Cüneyt Türkeş
Archives of Biochemistry and Biophysics (2024), pp. 110161-110161
Closed Access | Times Cited: 4
The Aldose Reductase Inhibitor Epalrestat Maintains Blood–Brain Barrier Integrity by Enhancing Endothelial Cell Function during Cerebral Ischemia
Tongshuai Zhang, Jinrong Wu, Yao Xin-min, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 7, pp. 3741-3757
Open Access | Times Cited: 8
Aldo-keto reductases: Role in cancer development and theranostics
Siddavaram Nagini, Prathap Reddy Kallamadi, Kranthi Kiran Kishore Tanagala, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 8, pp. 1287-1308
Open Access | Times Cited: 2
Esterase-Responsive Fluorogenic Prodrugs of Aldose Reductase Inhibitor Epalrestat: An Innovative Strategy toward Enhanced Anticancer Activity
Roopjyoti Misra, Pallavi Barman, Krishna P. Bhabak
ACS Applied Bio Materials (2024) Vol. 7, Iss. 10, pp. 6542-6553
Closed Access | Times Cited: 2
Polyol pathway-generated fructose is indispensable for growth and survival of non-small cell lung cancer
Annemarie Schwab, Aarif Siddiqui, Vignesh Ramesh, et al.
Cell Death and Differentiation (2024)
Open Access | Times Cited: 2
Functionally substituted derivatives of novel thiourea and phenylthiourea as potent aldose reductase, α-amylase, and α-glycosidase inhibitors: in vitro and in silico studies
Afsun Sujayev, Nastaran Sadeghian, Parham Taslimi, et al.
Macromolecular Research (2024) Vol. 32, Iss. 6, pp. 565-579
Closed Access | Times Cited: 1
Decoding selectivity: computational insights into AKR1B1 and AKR1B10 inhibition
Mingyue Liu, Xiaochun Qin, Jing Li, et al.
Physical Chemistry Chemical Physics (2024) Vol. 26, Iss. 12, pp. 9295-9308
Closed Access | Times Cited: 1
Bioinformatics Analysis Reveals the Vital Role of AKR1B1 in Immune Infiltration and Clinical Outcomes of Gastric Cancer
Zhiyue Zhao, Zhibin Hao, Zheng Zhang, et al.
DNA and Cell Biology (2023) Vol. 42, Iss. 7, pp. 372-389
Closed Access | Times Cited: 4
Aldo-keto reductase 1B: Much learned, much more to do
Yaya Zhao, Miaomiao Zhang, Huaping Li, et al.
hLife (2023) Vol. 2, Iss. 4, pp. 154-178
Open Access | Times Cited: 3
Cancer to Cataracts: The Mechanistic Impact of Aldo-Keto Reductases in Chronic Diseases
Anirudh P. Shanbhag, Purnendu Bhowmik
The Yale Journal of Biology and Medicine (2024) Vol. 97, Iss. 2, pp. 179-204
Open Access
Multi-target anticancer activity of compounds isolated from galls of Pistacia chinensis subsp. integerrima: A mechanistic investigation
Abdur Rauf, M. Israr Khan, Arsalan Nizamani, et al.
Phytochemistry Letters (2024) Vol. 64, pp. 6-12
Closed Access
Thiostrepton: multifaceted biological activities and its applications in treatment of inflammatory diseases
Aiminuer Asikaer, Cai Sun, Yan Shen
Inflammopharmacology (2024)
Closed Access
Rational design and synthesis of novel N-benzylindole-based epalrestat analogs as selective aldose reductase inhibitors: An unexpected discovery of a new glucose-lowering agent (AK-4) acting as a mitochondrial uncoupler
Antonios Kousaxidis, Paolo Paoli, Lucia Kováčiková, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117035-117035
Closed Access
AKR1B10 and digestive tumors development: a review
Yao Shen, Ailin Qiu, Xin Huang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
A new look for the management of Painful Peripheral Neuropathy in Diabetes
Mamdouh Elnahaas
Medicine Updates (2022) Vol. 12, Iss. 12, pp. 110-127
Open Access
Page 1

Scroll to top